QLGN

Qualigen Therapeutics News

Company Name Stock Ticker Symbol Market Type
Qualigen Therapeutics Inc QLGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0025 -0.58% 0.425 10:05:08
Open Price Low Price High Price Close Price Prev Close
0.429 0.417 0.429 0.4275
more quote information »

Recent News

Date Time Source Heading
8/08/202206:05EDGARNotice of Effectiveness (effect)
8/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/01/202212:45EDGARSeperately Filed Delaying Amendment Under Securities Act..
8/01/202208:30GLOBEQualigen Therapeutics Reports Positive QN-247 Readout in..
7/06/202209:00GLOBEQualigen Therapeutics Announces Partnership with Hande..
6/30/202206:05EDGARNotice of Effectiveness (effect)
6/22/202216:56EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202216:16EDGARSecurities Registration Statement (simplified Form) (s-3)
6/15/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202209:00GLOBEQualigen Therapeutics to Present at BIO International..
6/07/202209:04GLOBEQualigen Therapeutics Announces IND-Enabling Studies to..
6/02/202209:11EDGARCurrent Report Filing (8-k)
6/02/202209:00GLOBEQualigen Therapeutics Acquires Majority Stake in Infectious..
5/27/202209:22EDGARAmended Statement of Ownership (sc 13g/a)
5/26/202209:15GLOBEQualigen Therapeutics’ Pan-RAS Inhibitor Featured in Two..
5/20/202209:15GLOBEQualigen Therapeutics to Present at the H.C. Wainwright..
5/13/202206:12EDGARCurrent Report Filing (8-k)
5/13/202206:00GLOBEQualigen Therapeutics, Inc. Provides Corporate Update and..
5/10/202209:17GLOBEQualigen Therapeutics’ Partner NanoSynex to Present..
5/04/202216:08EDGARCurrent Report Filing (8-k)
5/03/202209:17GLOBEQualigen Therapeutics to Acquire Majority Stake in..
4/29/202209:15GLOBEQualigen Therapeutics Appoints Shishir Sinha to Lead..
4/12/202210:15GLOBEQualigen Therapeutics Presents Three Posters of QN-302 at..
4/05/202209:45SEEKQualigen Therapeutics climbs 3% on resuming worldwide..
4/05/202209:15GLOBEQualigen Therapeutics Resumes Worldwide Distribution and..
4/01/202209:00SEEKQualigen Therapeutics GAAP EPS of -$0.61, revenue of $5.65M
4/01/202208:00GLOBEQualigen Therapeutics, Inc. Reports Year-End 2021 Financial..
3/30/202212:09SEEKQualigen contracts TD2 for preclinical development of QN-302
3/30/202209:15GLOBEQualigen Therapeutics Engages TD2 as Contract Research..
3/22/202209:15GLOBEQualigen Therapeutics Announces Three Published Abstracts at..
3/15/202209:15GLOBEQualigen Therapeutics Extends Research Agreement with..
2/22/202209:15GLOBEQualigen Therapeutics CEO Michael Poirier Provides Letter to..
2/15/202209:15GLOBEData from Qualigen Therapeutics’ Lead Program QN-302..
2/01/202209:15GLOBEQualigen Therapeutics Engages Professor Stephen Neidle as..
1/18/202209:31EDGARCurrent Report Filing (8-k)
1/18/202209:15GLOBEQualigen Therapeutics Secures Worldwide Rights to..
1/05/202206:02EDGARAmended Statement of Ownership (sc 13g/a)
12/17/202106:17EDGARCurrent Report Filing (8-k)
12/14/202109:18GLOBEQualigen Therapeutics Promotes Amy Broidrick to President
12/10/202113:10EDGARCurrent Report Filing (8-k)
12/10/202106:15EDGARStatement of Changes in Beneficial Ownership (4)
12/10/202106:15EDGARStatement of Changes in Beneficial Ownership (4)


Your Recent History
NASDAQ
QLGN
Qualigen T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now